Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1844 1
1850 1
1899 1
1936 1
1943 1
1946 3
1947 8
1949 9
1950 6
1951 5
1952 6
1953 1
1954 2
1955 1
1956 1
1958 1
1961 3
1962 1
1963 3
1964 1
1966 1
1981 1
1983 1
1986 1
1987 1
1988 2
1989 4
1991 3
1992 4
1993 7
1994 6
1995 11
1996 5
1997 14
1998 7
1999 5
2000 12
2001 3
2002 12
2003 6
2004 8
2005 8
2006 8
2007 10
2008 11
2009 16
2010 16
2011 12
2012 14
2013 15
2014 14
2015 22
2016 37
2017 27
2018 22
2019 29
2020 29
2021 37
2022 30
2023 19
2024 3

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 14735480

505 results

Results by year

Filters applied: . Clear all
Page 1
Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.
Yoshida T, Kato J, Inoue I, Yoshimura N, Deguchi H, Mukoubayashi C, Oka M, Watanabe M, Enomoto S, Niwa T, Maekita T, Iguchi M, Tamai H, Utsunomiya H, Yamamichi N, Fujishiro M, Iwane M, Takeshita T, Ushijima T, Ichinose M. Yoshida T, et al. Int J Cancer. 2014 Mar 15;134(6):1445-57. doi: 10.1002/ijc.28470. Epub 2013 Oct 3. Int J Cancer. 2014. PMID: 24009139 Free article.
Eradication of Helicobacter pylori prevents cancer development in subjects with mild gastric atrophy identified by serum pepsinogen levels.
Yanaoka K, Oka M, Ohata H, Yoshimura N, Deguchi H, Mukoubayashi C, Enomoto S, Inoue I, Iguchi M, Maekita T, Ueda K, Utsunomiya H, Tamai H, Fujishiro M, Iwane M, Takeshita T, Mohara O, Ichinose M. Yanaoka K, et al. Int J Cancer. 2009 Dec 1;125(11):2697-703. doi: 10.1002/ijc.24591. Int J Cancer. 2009. PMID: 19610064 Free article.
Development of gastric cancer in nonatrophic stomach with highly active inflammation identified by serum levels of pepsinogen and Helicobacter pylori antibody together with endoscopic rugal hyperplastic gastritis.
Watanabe M, Kato J, Inoue I, Yoshimura N, Yoshida T, Mukoubayashi C, Deguchi H, Enomoto S, Ueda K, Maekita T, Iguchi M, Tamai H, Utsunomiya H, Yamamichi N, Fujishiro M, Iwane M, Tekeshita T, Mohara O, Ushijima T, Ichinose M. Watanabe M, et al. Int J Cancer. 2012 Dec 1;131(11):2632-42. doi: 10.1002/ijc.27514. Epub 2012 Mar 28. Int J Cancer. 2012. PMID: 22383377 Free article.
Helicobacter pylori, chronic atrophic gastritis, inactive aldehyde dehydrogenase-2, macrocytosis and multiple upper aerodigestive tract cancers and the risk for gastric cancer in alcoholic Japanese men.
Yokoyama A, Yokoyama T, Omori T, Matsushita S, Mizukami T, Takahashi H, Higuchi S, Maruyama K, Ishii H, Hibi T. Yokoyama A, et al. J Gastroenterol Hepatol. 2007 Feb;22(2):210-7. doi: 10.1111/j.1440-1746.2006.04377.x. J Gastroenterol Hepatol. 2007. PMID: 17295873
The association between precancerous gastric lesions and serum pepsinogens, serum gastrin, vascular endothelial growth factor, serum interleukin-1 Beta, serum toll-like receptor-4 levels and Helicobacter pylori Cag A status.
Yakut M, Örmeci N, Erdal H, Keskin O, Karayel Z, Tutkak H, Soykan I. Yakut M, et al. Clin Res Hepatol Gastroenterol. 2013 Jun;37(3):302-11. doi: 10.1016/j.clinre.2012.09.013. Epub 2012 Nov 6. Clin Res Hepatol Gastroenterol. 2013. PMID: 23137754
505 results